Oligometastatic head and neck cancer: Which patients benefit from radical local treatment of all tumour sites?

Oligometastatic head and neck cancer: Which patients benefit from radical local treatment of all tumour sites?

Abstract Background There is a large lack of evidence for optimal treatment in oligometastatic head and neck cancer and it is especially unclear which patients benefit from radical local treatment of all tumour sites. Methods 40 patients with newly diagnosed oligometastatic head and neck cancer rece...

Full description

Bibliographic Details
Main Authors: Thomas Weissmann, Daniel Höfler, Markus Hecht, Sabine Semrau, Marlen Haderlein, Irina Filimonova, Benjamin Frey, Christoph Bert, Sebastian Lettmaier, Konstantinos Mantsopoulos, Heinrich Iro, Rainer Fietkau, Florian Putz
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Radiation Oncology
Subjects:
Oligometastatic disease
Local treatment
Radiotherapy
SBRT
Head and neck cancer
Online Access:https://doi.org/10.1186/s13014-021-01790-w

Similar Items

Similar Items